\documentclass{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
%\usetheme{Warsaw}
%\usetheme{Antibes}
\usecolortheme{beaver}
%\usecolortheme{seahorse}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
\title{The Main Title Naming Key Concepts}
\subtitle{A subtitle may be shorter and more technical}
\author{Attila Jones}
\date{}

\begin{document}

\begin{frame}{Two related studies on drug repurposing}
\begin{columns}[t]
\begin{column}{0.5\textwidth}
\begin{itemize}
\item Sci Transl Med 2017
\item {\footnotesize The druggable genome and support for target identification and
	validation in drug development}
\end{itemize}
\end{column}

\begin{column}{0.5\textwidth}
\begin{itemize}
\item Nature Medicine 2021
\item {\footnotesize Actionable druggable genome-wide Mendelian randomization
	identifies repurposing opportunities for COVID-19}
\end{itemize}
\end{column}
\end{columns}
\begin{center}
The relation
\begin{enumerate}
\item druggable genome
\item GWAS
\item authors
\end{enumerate}
\end{center}
\end{frame}

\begin{frame}{Druggable genes in GWAS intervals}
\begin{itemize}
\item druggable: ``potential to be modulated by a drug-like small
	molecule''\footnote{Sci Transl Med 2017}
\item 20\% of the 20,000 proteins coding genes are druggable
\begin{itemize}
\item structural similarity to approved drugs and their targets
\end{itemize}
\item 10\% of the 5,000 GWAS intervals contain druggable gene(s)
\begin{itemize}
\item GWAS catalog
\end{itemize}
\end{itemize}

\vfill
Resulting associations:\\
druggable genes targets of licenced drugs --- indication/phenotype
\begin{enumerate}
\item rediscover targets of licenced drugs for known indication
\item repurposing: ... for novel indication(s)
\end{enumerate}
\end{frame}

\section{Sci Transl Med 2017}

\begin{frame}{Repurposing opportunities}
\includegraphics[height=0.8\textheight]{from-others/finan-2017-sci-transl-med-fig4.png}
\end{frame}

\begin{frame}{Case studies}
\includegraphics[height=0.8\textheight]{from-others/finan-2017-sci-transl-med-fig6.png}
\end{frame}

\begin{frame}{Nature Medicine 2021 design}
\includegraphics[height=0.8\textheight]{from-others/gaziano-2021-nature-med-fig1.png}
\end{frame}

\begin{frame}{Nature Medicine 2021 MR results}
\includegraphics[width=1.0\textwidth]{from-others/gaziano-2021-nature-med-fig2.png}
\end{frame}

\begin{frame}{Data and tools}
\begin{itemize}
\item druggable, actionable genes
\item GWAS summary statistics
\item GTEx, \texttt{Matrix eQTL} R package, Nature Med 2021 Table S4
\item \texttt{TwoSampleMR} R package
\end{itemize}
\end{frame}

\begin{frame}{Reproducibility}{From the \texttt{TwoSampleMR} website}
\begin{columns}[t]
\begin{column}{0.7\textwidth}

\includegraphics[width=1.0\columnwidth]{from-others/twosamplemr_schematic_long-01A.png}
\includegraphics[width=1.0\columnwidth]{from-others/twosamplemr_schematic_long-01B4.png}
\end{column}

\begin{column}{0.5\textwidth}
\footnotesize
\begin{description}
\item[Exposure] $g$ expression, $g \in$ actionable genome
\item[Outcome] COVID-19 hospitalization
\end{description}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{Only 1 variant for most MR experiments}
\includegraphics[scale=0.6]{named-figure/ST7-hist.pdf}
\end{frame}

\end{document}

\begin{columns}[t]
\begin{column}{0.5\textwidth}

\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
